Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics · Albers-Schönberg disease

The Science of Dense Bone: Biology, Genetics, and Imaging

At a Glance

Albers-Schönberg disease (ADO II) is a genetic condition where a mutated CLCN7 gene prevents cells from breaking down old bone, causing bones to become overly dense and brittle. It is an autosomal dominant condition, meaning there is a 50% chance of passing the mutation to your children.

Understanding the biology of Albers-Schönberg disease (ADO II) requires looking deep into the cellular machinery that builds and maintains your skeleton. While it may feel like your bones are simply “growing too much,” the reality is more like a construction site where the builders are working perfectly, but the demolition crew has gone on strike [1][2].

The Biology: A Demolition Crew Without Tools

Your bones are living tissue that must be constantly “remodeled”—broken down and rebuilt—to stay strong and flexible. This process relies on osteoclasts, specialized cells that act as a demolition crew [2].

To break down bone, osteoclasts must create a highly acidic environment, similar to stomach acid, to dissolve the hard minerals [3]. This acidification is powered by a “pump” called the ClC-7 chloride/hydrogen antiporter [4]. In ADO II, a mutation in the CLCN7 gene breaks this pump [5]. Without it, the osteoclasts cannot produce the acid needed to dissolve old bone. Because the bone-building cells (osteoblasts) continue to work normally, bone keeps piling up, becoming incredibly dense but structurally brittle [4][1].

Genetics: The 50% Risk

ADO II is an autosomal dominant condition. This means you only need one copy of the mutated gene to have the disease.

  • Dominant Negative Effect: Most ADO II mutations (like the common R286W variant) are “dominant negative” [6]. This means the “broken” version of the protein doesn’t just sit idle; it actually interferes with the “healthy” version produced by your other, normal copy of the gene, making the overall acidification process even less efficient [7][4].
  • Inheritance: Because you have one mutated copy and one healthy copy, there is a 50% chance in every pregnancy that you will pass the mutated gene to your child [7].

Action Step for Families: If you are diagnosed as an adult, it is highly recommended to seek a genetic counselor. They can help determine if your existing children, siblings, or parents should undergo genetic or radiographic screening, as the disease can be entirely asymptomatic in some people [7].

Decoding Your Radiology Report

When you read a report from an X-ray or CT scan, you may see specific terms that describe the unique way ADO II bones appear:

  • Sandwich Vertebrae: This refers to the spine. The top and bottom of each spinal bone (vertebra) become extremely dense, appearing bright white on an X-ray, while the middle stays darker. This creates a striped “sandwich” appearance [8][9].
  • Bone-within-Bone (Endobones): This occurs when a “miniature” version of the bone’s shape appears trapped inside the larger bone. It is a hallmark sign that the bone failed to remodel properly as you grew [10].
  • Loss of Corticomedullary Differentiation: This is perhaps the most important term. Normally, bone has a hard outer shell (cortex) and a soft, hollow center (medulla) where bone marrow lives. In ADO II, the entire bone becomes dense, and the “line” between the shell and the center disappears [9][2]. This can lead to bone marrow cavity stenosis (narrowing), which may eventually affect your body’s ability to produce blood cells [1].

ADO II vs. Infantile ARO

It is important to distinguish your condition from the more severe form of the disease:

  • ADO II (Autosomal Dominant): Usually diagnosed in late childhood or adulthood. It is generally milder, focusing on fractures and dental issues, with a normal life expectancy [11][12].
  • ARO (Autosomal Recessive): A severe, life-threatening form that begins in infancy. It occurs when a child inherits two mutated genes (one from each parent). ARO causes total bone marrow failure and severe nerve damage very early in life [13][14].

Knowing your specific mutation through genetic testing can help your care team monitor your unique risks and distinguish between these two forms [4].

Common questions in this guide

Why do bones become so dense in Albers-Schönberg disease?
In ADO II, bone-destroying cells called osteoclasts have a broken 'pump' and cannot produce the acid needed to dissolve old bone. Because bone-building cells keep working normally, bone continues to pile up, becoming very dense but structurally weak.
What is the chance of passing ADO II to my children?
ADO II is an autosomal dominant condition, meaning you only need one mutated copy of the gene to have the disease. Because of this, there is a 50 percent chance in every pregnancy of passing the mutation to your child.
What does 'sandwich vertebrae' mean on my radiology report?
'Sandwich vertebrae' describes the appearance of spinal bones on an X-ray where the top and bottom of each bone become extremely dense and bright white, while the middle stays darker. This creates a striped pattern characteristic of ADO II.
What is the difference between ADO II and infantile ARO?
ADO II is usually diagnosed in adulthood, has a normal life expectancy, and causes mostly bone fractures and dental issues. Infantile ARO is a much more severe, life-threatening form that begins in infancy and causes total bone marrow failure.
Why is genetic counseling recommended for ADO II?
A genetic counselor can help you understand your specific CLCN7 gene mutation and coordinate screening for your family. This is crucial because the disease can sometimes be completely silent or asymptomatic in your parents, siblings, or children.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my specific CLCN7 mutation (e.g., R286W) have a known 'dominant negative' effect, and what does that mean for my symptoms?
  2. 2.In my radiology report, how extensive is the 'loss of corticomedullary differentiation,' and does it suggest my bone marrow space is becoming compromised?
  3. 3.Can you explain how the 'sandwich vertebrae' seen in my X-rays might be related to any back pain or stiffness I am experiencing?
  4. 4.Given that this is an autosomal dominant condition, how should we approach screening my siblings or children who have no symptoms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Clinical and molecular characterization of five Chinese patients with autosomal recessive osteopetrosis.

    Liang H, Li N, Yao RE, et al.

    Molecular genetics & genomic medicine 2021; (9(11)):e1815 doi:10.1002/mgg3.1815.

    PMID: 34545712
  2. 2

    Imaging in osteopetrosis.

    Calder AD, Arulkumaran S, D'Arco F

    Bone 2022; (165()):116560 doi:10.1016/j.bone.2022.116560.

    PMID: 36116759
  3. 3

    Null mutation of chloride channel 7 (Clcn7) impairs dental root formation but does not affect enamel mineralization.

    Guo J, Bervoets TJ, Henriksen K, et al.

    Cell and tissue research 2016; (363(2)):361-70 doi:10.1007/s00441-015-2263-z.

    PMID: 26346547
  4. 4

    CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis.

    Stauber T, Wartosch L, Vishnolia S, et al.

    Bone 2023; (168()):116639 doi:10.1016/j.bone.2022.116639.

    PMID: 36513280
  5. 5

    Autosomal dominant osteopetrosis associated with renal tubular acidosis is due to a CLCN7 mutation.

    Piret SE, Gorvin CM, Trinh A, et al.

    American journal of medical genetics. Part A 2016; (170(11)):2988-2992 doi:10.1002/ajmg.a.37755.

    PMID: 27540713
  6. 6

    SUGAR-seq reveals the transcriptome and N-linked glycosylation landscape of mononuclear phagocytes at single-cell resolution in a mouse model of autosomal dominant osteopetrosis type 2.

    Sha Y, Huang L, Zhang L, et al.

    BMC biology 2025; (23(1)):91 doi:10.1186/s12915-025-02193-z.

    PMID: 40165215
  7. 7

    Clcn7F318L/+ as a new mouse model of Albers-Schönberg disease.

    Caetano-Lopes J, Lessard SG, Hann S, et al.

    Bone 2017; (105()):253-261 doi:10.1016/j.bone.2017.09.007.

    PMID: 28942122
  8. 8

    Osteopetrosis - Classic Imaging Findings in the Spine.

    Kirkland JD, O'Brien WT

    Journal of clinical and diagnostic research : JCDR 2015; (9(8)):TJ01-2 doi:10.7860/JCDR/2015/13334.6348.

    PMID: 26436019
  9. 9

    Paediatric bilateral femoral neck fractures in osteopetrosis treated conservatively.

    Kumar S, Dhammi IK, Shahi P, Zafar A

    BMJ case reports 2020; (13(12)) doi:10.1136/bcr-2020-236891.

    PMID: 33318240
  10. 10

    Autosomal Dominant Osteopetrosis - Identification of a New Mutation.

    Monteiro I, Moutinho-Pereira S, Kornak U, Carneiro L

    European journal of case reports in internal medicine 2025; (12(12)):006042 doi:10.12890/2025_006042.

    PMID: 41536451
  11. 11

    Management of Osteomyelitis in Autosomal Dominant Osteopetrosis: A Rare Case Report.

    Almutairi M, Alharbi A, Almutairi H, et al.

    Cureus 2024; (16(6)):e62660 doi:10.7759/cureus.62660.

    PMID: 39036270
  12. 12

    Malignant Infantile Osteopetrosis.

    Gillani S, Abbas Z

    Journal of Ayub Medical College, Abbottabad : JAMC 2017; (29(2)):350-352.

    PMID: 28718264
  13. 13

    Novel CLCN7 mutations cause autosomal dominant osteopetrosis type II and intermediate autosomal recessive osteopetrosis.

    Li L, Lv SS, Wang C, et al.

    Molecular medicine reports 2019; (19(6)):5030-5038 doi:10.3892/mmr.2019.10123.

    PMID: 30942407
  14. 14

    Osteopetrosis and related osteoclast disorders in adults: A review and knowledge gaps On behalf of the European calcified tissue society and ERN BOND.

    Funck-Brentano T, Zillikens MC, Clunie G, et al.

    European journal of medical genetics 2024; (69()):104936 doi:10.1016/j.ejmg.2024.104936.

    PMID: 38593953

This page explains the biology, genetics, and radiology of Albers-Schönberg disease for educational purposes only. Always discuss your specific genetic test results and imaging reports with your doctor or a certified genetic counselor.

Get notified when new evidence is published on Albers-Schönberg osteopetrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.